Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Safety and Efficiency of AND017 in Patients With Transfusion Dependent and Non-transfusion Dependent β-thalassemia

NCT06302491 is registered in ClinicalTrials.gov with Kind Pharmaceuticals LLC as lead sponsor.

NCT NCT06302491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Safety and Efficiency of AND017 in Patients With Transfusion Dependent and Non-transfusion Dependent β-thalassemia
Lead sponsor
Kind Pharmaceuticals LLC
Phase
Phase 2
Overall status
Recruiting
Start date
May 27, 2024
Completion date
July 31, 2027
Enrollment
64 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

β -thalassemia